Memorial Sloan Kettering Cancer Center Updates in Thrombosis & Hemostasis 2024

Memorial Sloan Kettering Cancer Center Updates in Thrombosis & Hemostasis 2024

50 $

Format : 17 videos + 17 pdfs

File size: 3.33 GB

Category:

Date & Location Sunday, October 27, 2024, 9:00 AM – 3:00 PM, Zuckerman Research Center, New York, NY

Specialties Specialties – Emergency Medicine, Hematology, Hematopathology, Hospitalist, Internal Medicine, Interventional Radiology, Oncology and Hematology
Overview

This symposium aims to deliver the latest updates in benign hematology, with a special emphasis on venous thromboembolism and anticoagulation. The 2024 program will focus on three main areas:

  • Current challenges in Venous Thromboembolism (VTE)
  • Novel anticoagulants
  • Thrombotic complications of clonal disorders

Key topics will include thrombophilia testing, the role of interventional radiology in VTE management, and challenging scenarios such as chronic thromboembolic pulmonary hypertension (CTEPH), refractory thrombosis, and splanchnic thrombosis. Additionally, faculty will review the reversal of direct oral anticoagulants, novel factor XI inhibitors, and unique challenges in the management of thrombosis and clonal disorders (e.g., PNH and myeloproliferative neoplasm). Ample time will be allocated for Q&A and discussions with the faculty.

The target audience includes general medicine practitioners, hematologists/oncologists, intensivists, emergency medicine practitioners, primary care physicians, residents, fellows, advanced practice providers, and other healthcare professionals involved in the management and treatment of thrombotic and bleeding disorders.

Objectives
At the conclusion of this symposium, attendees will be able to:
  1. Provide guidance and updates on management of challenging thrombotic conditions including indications for thrombophilia testing, role of interventional radiology, management of refractory thrombosis, PNH, and anticoagulation in brain tumors.
  2. Summarize recent data on management of anticoagulant related hemorrhage and discuss emerging FXI inhibitors and their potential for improved safety profiles.
  3. Recognize the challenges in managing thrombo-hemorrhagic risks in patients with myeloproliferative neoplasms.

 

+ Topics:

Anticoagulation in Thrombocytopenic Patients.mp4
Anticoagulation in Thrombocytopenic Patients.pdf
Approach to Anticoagulation in Brain Tumors.mp4
Approach to Anticoagulation in Brain Tumors.pdf
BenignHeme2024_Brochure.pdf
Bleeding with Direct Oral Anticoagulants.mp4
Bleeding with Direct Oral Anticoagulants.pdf
Factor XI Inhibitors- The Holy Grail of Anticoagulants.mp4
Factor XI Inhibitors- The Holy Grail of Anticoagulants.pdf
Hematologic Complications of Immunotherapy.mp4
Hematologic Complications of Immunotherapy.pdf
Indications and Safety of Combined Antiplatelet and Anticoagulant Therapy.mp4
Indications and Safety of Combined Antiplatelet and Anticoagulant Therapy.pdf
Ins and Outs of Chronic Thromboembolic Pulmonary Hypertension.mp4
Ins and Outs of Chronic Thromboembolic Pulmonary Hypertension.pdf
Myeloproliferative Disease and Thrombosis.mp4
Myeloproliferative Disease and Thrombosis.pdf
Patient Perspective – Living with Venous Thromboembolism.mp4
Patient Perspective – Living with Venous Thromboembolism.pdf
Peri-Operative Management of Myeloproliferative Neoplasms.mp4
Peri-Operative Management of Myeloproliferative Neoplasms.pdf
Role of Interventional Radiology in Managing Venous Thromboembolism.mp4
Role of Interventional Radiology in Managing Venous Thromboembolism.pdf
ROUNDTABLE DISCUSSION – Myeloproliferative Neoplasms and Thrombosis.mp4
Testing for Thrombophilia on Anticoagulants.mp4
Testing for Thrombophilia on Anticoagulants.pdf
The Challenge of Refractory Thrombosis.mp4
The Challenge of Refractory Thrombosis.pdf
Thrombophilia Testing – Who, When, and Why.mp4
Thrombophilia Testing – Who, When, and Why.pdf
Thrombosis and Breast Cancer Therapy.mp4
Thrombosis and Breast Cancer Therapy.pdf
Thrombosis and Paroxysmal Nocturnal Hemoglobinuria.mp4
Thrombosis and Paroxysmal Nocturnal Hemoglobinuria.pdf

Reviews

There are no reviews yet.

Be the first to review “Memorial Sloan Kettering Cancer Center Updates in Thrombosis & Hemostasis 2024”

Related Products